Published in J Hematother Stem Cell Res on December 01, 2000
Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther (2002) 2.63
Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes (2009) 1.78
Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther (2008) 1.75
Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression. Proc Natl Acad Sci U S A (2008) 1.54
Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem Cells (2008) 1.46
Ex vivo expansion of cord blood. Bone Marrow Transplant (2009) 1.46
Hematopoietic stem cells in co-culture with mesenchymal stromal cells--modeling the niche compartments in vitro. Haematologica (2010) 1.30
CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties. Haematologica (2010) 1.30
Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells. Immunol Cell Biol (2013) 1.29
Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells. PLoS One (2012) 1.29
Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation? Langenbecks Arch Surg (2011) 1.26
PAX6 expression identifies progenitor cells for corneal keratocytes. FASEB J (2005) 1.22
Bone marrow and the control of immunity. Cell Mol Immunol (2011) 1.15
In vitro Differentiation Potential of Mesenchymal Stem Cells. Transfus Med Hemother (2008) 1.12
Mesenchymal stromal cells: a new tool against graft-versus-host disease? Biol Blood Marrow Transplant (2011) 1.11
Bone marrow osteoblastic niche: a new model to study physiological regulation of megakaryopoiesis. PLoS One (2009) 1.08
Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease. Adv Hematol (2011) 0.97
The bone marrow microenvironment as a sanctuary for minimal residual disease in CML. Biochem Pharmacol (2010) 0.96
Paracrine molecules of mesenchymal stem cells for hematopoietic stem cell niche. Bone Marrow Res (2011) 0.96
Overcoming the barriers to umbilical cord blood transplantation. Cytotherapy (2010) 0.96
Cytokine secretion profiling of human mesenchymal stem cells by antibody array. Int J Stem Cells (2009) 0.93
Mesenchymal stem cells: a potential border patrol for transplanted islets? Diabetes (2009) 0.93
Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions. Biol Blood Marrow Transplant (2009) 0.92
Structure and function of the hematopoietic cancer niche: focus on chronic lymphocytic leukemia. Front Biosci (Schol Ed) (2012) 0.91
Stromal cell-free conditions favorable for human B lymphopoiesis in culture. J Immunol Methods (2010) 0.88
Immune Modulation by Mesenchymal Stem Cells. Transfus Med Hemother (2008) 0.86
Comparative analysis of gene transcripts for cell signaling receptors in bone marrow-derived hematopoietic stem/progenitor cell and mesenchymal stromal cell populations. Stem Cell Res Ther (2013) 0.85
Reconciling the effects of inflammatory cytokines on mesenchymal cell osteogenic differentiation. J Surg Res (2013) 0.84
Effect of activated autologous platelet-rich plasma on proliferation and osteogenic differentiation of human adipose-derived stem cells in vitro. Am J Transl Res (2015) 0.84
Mesenchymal stem cells derived in vitro transdifferentiated insulin-producing cells: A new approach to treat type 1 diabetes. Adv Biomed Res (2014) 0.83
microRNAs as regulators of adipogenic differentiation of mesenchymal stem cells. Stem Cells Dev (2014) 0.82
Isolation of adipose-derived stromal cells without enzymatic treatment: expansion, phenotypical, and functional characterization. Stem Cells Dev (2014) 0.82
Cotransplantation of cord blood hematopoietic stem cells and culture-expanded and GM-CSF-/SCF-transfected mesenchymal stem cells in SCID mice. J Korean Med Sci (2007) 0.81
Characterization of mononucleated human peripheral blood cells. ScientificWorldJournal (2012) 0.80
Simultaneous expansion and harvest of hematopoietic stem cells and mesenchymal stem cells derived from umbilical cord blood. J Mater Sci Mater Med (2010) 0.80
Interactions of human endothelial and multipotent mesenchymal stem cells in cocultures. Open Biomed Eng J (2010) 0.80
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties. PLoS One (2013) 0.79
Concise Review: Mesenchymal Stem Cells Ameliorate Tissue Injury via Secretion of Tumor Necrosis Factor-α Stimulated Protein/Gene 6. Stem Cells Int (2014) 0.78
The Effect of Bone Marrow Mesenchymal Stem Cells on Vitamin D3 Induced Monocytic Differentiation of U937 Cells. Adv Pharm Bull (2016) 0.78
Supernatant of bone marrow mesenchymal stromal cells induces peripheral blood mononuclear cells possessing mesenchymal features. Int J Biol Sci (2011) 0.78
Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis. Clin Exp Metastasis (2012) 0.78
Apoptosis of bone marrow mesenchymal stem cells caused by homocysteine via activating JNK signal. PLoS One (2013) 0.78
Prevention of graft-versus-host disease by intrabone marrow injection of donor T cells: involvement of bone marrow stromal cells. Clin Exp Immunol (2008) 0.78
Effect of Subcultivation of Human Bone Marrow Mesenchymal Stem on their Capacities for Chondrogenesis, Supporting Hematopoiesis, and Telomea Length. Cytotechnology (2005) 0.78
The Impact of Mesenchymal Stem Cells on Differentiation of Hematopoietic Stem Cells. Adv Pharm Bull (2015) 0.78
Mesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risks. Kidney Int Suppl (2011) (2011) 0.77
Role of mesenchymal stem cells in leukaemia: Dr. Jekyll or Mr. Hyde? Clin Exp Med (2013) 0.77
The Effect of Bone Marrow-Derived Mesenchymal Stem Cells and Their Conditioned Media Topically Delivered in Fibrin Glue on Chronic Wound Healing in Rats. Biomed Res Int (2015) 0.77
The involvement of multipotential progenitor cells in Mooren's ulcer. Yonsei Med J (2005) 0.77
Current progress of human trials using stem cell therapy as a treatment for diabetes mellitus. Am J Stem Cells (2016) 0.76
Pharmacokinetics of natural and engineered secreted factors delivered by mesenchymal stromal cells. PLoS One (2014) 0.76
Mesenchymal Cell Reprogramming in Experimental MPLW515L Mouse Model of Myelofibrosis. PLoS One (2017) 0.76
Modeling the Pro-inflammatory Tumor Microenvironment in Acute Lymphoblastic Leukemia Predicts a Breakdown of Hematopoietic-Mesenchymal Communication Networks. Front Physiol (2016) 0.76
Glycogen synthase kinase 3β promotes osteogenic differentiation of murine adipose-derived stromal cells. PLoS One (2013) 0.76
Enhanced adipogenicity of bone marrow mesenchymal stem cells in aplastic anemia. Stem Cells Int (2014) 0.75
Elevated expression of DNMT1 is associated with increased expansion and proliferation of hematopoietic stem cells co-cultured with human MSCs. Blood Res (2017) 0.75
Phenotypic and Functional Characterization of Mesenchymal Stem/Multipotent Stromal Cells from Decidua Basalis of Human Term Placenta. Stem Cells Int (2016) 0.75
Ability of circulating human hematopoietic lineage negative cells to support hematopoiesis. J Cell Biochem (2015) 0.75
Bone Marrow-Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality. Biol Blood Marrow Transplant (2017) 0.75
Induction of CXC chemokines in human mesenchymal stem cells by stimulation with secreted frizzled-related proteins through non-canonical Wnt signaling. World J Stem Cells (2015) 0.75
Osteogenic Differentiation of MSC through Calcium Signaling Activation: Transcriptomics and Functional Analysis. PLoS One (2016) 0.75
Apoptosis, DAP-Kinase1 Expression and the Influences of Cytokine Milieu and Mesenchymal Stromal Cells on Ex Vivo Expansion of Umbilical Cord Blood-Derived Hematopoietic Stem Cells. Indian J Hematol Blood Transfus (2015) 0.75
Effects of Mesenchymal Stem Cell Derivatives on Hematopoiesis and Hematopoietic Stem Cells. Adv Pharm Bull (2017) 0.75
Mesenchymal Stem Cell-Derived Factors Restore Function to Human Frataxin-Deficient Cells. Cerebellum (2017) 0.75
Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem (1997) 6.30
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med (2001) 5.14
Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem (1997) 4.68
Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol (2003) 4.62
Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol (2000) 3.94
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant (2002) 3.24
Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med (2001) 3.24
Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol (1998) 3.08
Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med (1984) 3.07
Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem (2000) 2.98
Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules. Br J Cancer (2003) 2.38
Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant (2004) 2.36
Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant (1995) 2.35
Construction and sequence of cDNA for rat liver stearyl coenzyme A desaturase. J Biol Chem (1986) 2.11
Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res (1987) 2.03
Antigen detection in the diagnosis of invasive aspergillosis. Utility in controlled, blinded trials. Ann Intern Med (1983) 1.59
Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol (1999) 1.55
Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant (1997) 1.55
Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF. J Clin Oncol (2000) 1.50
Polypharmacy in fatal clozapine-associated agranulocytosis. Lancet (1991) 1.50
Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res (1996) 1.47
Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents. Clin Cancer Res (1999) 1.46
Serodiagnosis of invasive aspergillosis in patients with hematologic malignancy: validation of the Aspergillus fumigatus antigen radioimmunoassay. J Infect Dis (1987) 1.44
Role of the latent transforming growth factor beta binding protein 1 in fibrillin-containing microfibrils in bone cells in vitro and in vivo. J Bone Miner Res (2000) 1.42
Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation. Clin Cancer Res (2001) 1.42
Comparison of O6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis (1986) 1.40
Mesenchymal stem cells: no longer second class marrow citizens. Nat Med (1999) 1.39
O6 alkylguanine-DNA alkyltransferase activity in human myeloid cells. J Clin Invest (1985) 1.33
Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy. Arch Intern Med (1983) 1.31
The induction and characterization of rat liver stearyl-CoA desaturase mRNA. J Biol Chem (1985) 1.31
The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase. Science (1993) 1.27
Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment. J Bone Joint Surg Am (2007) 1.27
Isolation of super-repressor mutants in the histidine utilization system of Salmonella typhimurium. J Bacteriol (1975) 1.26
A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp Cell Res (1995) 1.26
Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. Carcinogenesis (1995) 1.23
Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen. Cancer Chemother Pharmacol (2000) 1.23
Dilution of human mesenchymal stem cells with dermal fibroblasts and the effects on in vitro and in vivo osteochondrogenesis. Dev Dyn (2000) 1.21
Granulocyte colony-stimulating factor for clozapine-induced agranulocytosis. Lancet (1992) 1.21
O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair. Cancer Res (1999) 1.21
Mechanical loading stimulates rapid changes in periosteal gene expression. Calcif Tissue Int (1994) 1.17
Activation of peroxisome proliferator-activated receptor-gamma pathway inhibits osteoclast differentiation. J Biol Chem (2000) 1.16
Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transplant (1992) 1.16
Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer cells. Mutat Res (2001) 1.15
In vivo osteochondrogenic potential of cultured cells derived from the periosteum. Clin Orthop Relat Res (1990) 1.14
Temozolomide: the effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O(6)-alkylguanine-DNA-alkyltransferase. Clin Cancer Res (2001) 1.12
LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Hum Gene Ther (1997) 1.11
Gestational age-dependent changes in circulating hematopoietic stem cells in newborn infants. J Lab Clin Med (1989) 1.10
Bone and cartilage formation in diffusion chambers by subcultured cells derived from the periosteum. Bone (1990) 1.10
Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow. Cancer Res (1985) 1.10
Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies. Bone Marrow Transplant (2011) 1.09
Mesenchymal stem cells as vehicles for gene delivery. Clin Orthop Relat Res (2000) 1.09
Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells. J Cell Physiol (2000) 1.08
In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Exp Cell Res (1991) 1.07
Systemic deficits in transporter for antigen presentation (TAP)-1 or proteasome subunit LMP2 have little or no effect on tumor incidence. Int J Cancer (2001) 1.02
Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med (1984) 1.01
Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemia. Am Rev Respir Dis (1985) 1.00
Parathyroid hormone-related protein in the rat urinary bladder: a smooth muscle relaxant produced locally in response to mechanical stretch. Proc Natl Acad Sci U S A (1992) 0.99
Clozapine--deciphering the risks. N Engl J Med (1993) 0.98
Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days. J Clin Oncol (2001) 0.98
Characterization of the P140K, PVP(138-140)MLK, and G156A O6-methylguanine-DNA methyltransferase mutants: implications for drug resistance gene therapy. Hum Gene Ther (1999) 0.97
Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone (1997) 0.97
Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections. J Hematother (1997) 0.97
Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood (1995) 0.96
Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection. Blood (2000) 0.96
Comparison of the inactivation of mammalian and bacterial O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine and O6-methylguanine. Carcinogenesis (1991) 0.95
Alkaline phosphatase as a reporter enzyme. Gene (1988) 0.94
Bacterial synthesis of active rat stearyl-CoA desaturase lacking the 26-residue amino-terminal amino acid sequence. J Biol Chem (1988) 0.94
Increase in nitrosourea resistance in mammalian cells by retrovirally mediated gene transfer of bacterial O6-alkylguanine-DNA alkyltransferase. Cancer Res (1989) 0.94
Retroviral transduction of a mutant methylguanine DNA methyltransferase gene into human CD34 cells confers resistance to O6-benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosourea. Proc Natl Acad Sci U S A (1996) 0.92
Rapid repair of O6-methylguanine-DNA adducts protects transgenic mice from N-methylnitrosourea-induced thymic lymphomas. Cancer Res (1994) 0.91
Regulation of the hut operons of Salmonella typhimurium and Klebsiella aerogenes by the heterologous hut repressors. J Bacteriol (1975) 0.91
Prospective evaluation of a Candida antigen detection test for invasive candidiasis in immunocompromised adult patients with cancer. Am J Med (1989) 0.90
DNA repair modulates the vulnerability of the developing brain to alkylating agents. DNA Repair (Amst) (2009) 0.90
Removal of uracil by uracil DNA glycosylase limits pemetrexed cytotoxicity: overriding the limit with methoxyamine to inhibit base excision repair. Cell Death Dis (2012) 0.90
MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice. Oncogene (2001) 0.89
Invasive pulmonary aspergillosis and acute leukemia. Limitations in the diagnostic utility of the air crescent sign. Radiology (1985) 0.89
Carmustine and streptozocin in refractory melanoma: an attempt at modulation of O-alkylguanine-DNA-alkyltransferase. Clin Cancer Res (1996) 0.89
Production of parathyroid hormone-like peptide in a human osteosarcoma cell line: stimulation by phorbol esters and epidermal growth factor. J Endocrinol (1989) 0.89
Activity of temozolomide against human tumor colony-forming units. Clin Cancer Res (1997) 0.88
High level, regulated expression of the chimeric P-enolpyruvate carboxykinase (GTP)-bacterial O6-alkylguanine-DNA alkyltransferase (ada) gene in transgenic mice. Cancer Res (1990) 0.87
Repair of O6-alkylguanine during DNA synthesis in murine bone marrow hematopoietic precursors. Cancer Res (1987) 0.86
Enhanced repair of O6-methylguanine DNA adducts in the liver of transgenic mice expressing the ada gene. Cancer Res (1991) 0.86
Viral infection of vascular endothelial cells alters production of colony-stimulating activity. J Clin Invest (1985) 0.86
Reduced lung tumorigenesis in human methylguanine DNA--methyltransferase transgenic mice achieved by expression of transgene within the target cell. Carcinogenesis (1999) 0.86
Invasive pulmonary aspergillosis in adult acute leukemia: clinical clues to its diagnosis. J Clin Oncol (1985) 0.85
Splenectomy and the induction of murine colon cancer. Arch Surg (1988) 0.85
Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient mice. Oncogene (2001) 0.85
Incipient analysis of mesenchymal stem-cell-derived osteogenesis. J Dent Res (2001) 0.85
DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts. Hum Gene Ther (1999) 0.84
Quantitative immunohistochemical estimates of O6-alkylguanine-DNA alkyltransferase expression in normal and malignant human colon. Clin Cancer Res (1996) 0.84